Volition signs global supply agreement for nu.q® vet cancer test

Henderson, nev. , oct. 20, 2022 /prnewswire/ -- volitionrx limited (nyse american: vnrx) ("volition"), a multi-national epigenetics company, announces the signing of a global supply agreement with a market leader in pet healthcare (the "company").
VNRX Ratings Summary
VNRX Quant Ranking